Scientists test two forms of cholesterol drug in healthy volunteers
NCT ID NCT07422285
Summary
This early-stage study aims to understand how two different versions of the cholesterol-lowering drug evolocumab are absorbed and processed by the body. It will involve 400 healthy adults who will receive a single dose. The main goal is to compare how much of each drug version gets into the bloodstream and how long it stays there.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fortrea Clinical Research Unit - Dallas
RECRUITINGDallas, Texas, 75247, United States
-
Fortrea Clinical Research Unit - Daytona Beach
RECRUITINGDaytona Beach, Florida, 32117-5116, United States
-
Fortrea Clinical Research Unit Inc. - Madison
RECRUITINGMadison, Wisconsin, 53704-2526, United States
-
QPS Bio-Kinetic
RECRUITINGSpringfield, Missouri, 65802-4842, United States
Conditions
Explore the condition pages connected to this study.